.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Baxter
McKinsey
Farmers Insurance
Johnson and Johnson
Fish and Richardson
Healthtrust
Citi
Accenture
Medtronic

Generated: September 20, 2017

DrugPatentWatch Database Preview

Carbidopa; levodopa - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for carbidopa; levodopa and what is the scope of carbidopa; levodopa patent protection?

Carbidopa; levodopa
is the generic ingredient in seven branded drugs marketed by Mayne Pharma, Impax Labs Inc, Apotex, Apotex Inc, Idt Australia Ltd, Impax Labs, Accord Hlthcare, Mylan, Sun Pharm Inds, Ranbaxy, Abbvie Inc, Merck Sharp Dohme, Actavis Elizabeth, Kv Pharm, SCS, Watson Labs, Sun Pharma Global, and Ucb Inc, and is included in twenty-nine NDAs. There are eight patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Carbidopa; levodopa has thirty-four patent family members in thirteen countries.

There are eighteen drug master file entries for carbidopa; levodopa. Thirty-two suppliers are listed for this compound.

Summary for Generic Name: carbidopa; levodopa

Tradenames:7
Patents:8
Applicants:18
NDAs:29
Drug Master File Entries: see list18
Suppliers / Packagers: see list32
Clinical Trials: see list340
Therapeutic Class:Antiparkinson Agents
Drug Prices:see low prices
DailyMed Link:carbidopa; levodopa at DailyMed

Pharmacology for Ingredient: carbidopa; levodopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL078536-002Oct 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Ucb Inc
PARCOPA
carbidopa; levodopa
TABLET, ORALLY DISINTEGRATING;ORAL076699-002Aug 27, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL074260-003Sep 3, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-003Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Mylan
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET;ORAL090324-002Sep 28, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
RYTARY
carbidopa; levodopa
CAPSULE, EXTENDED RELEASE;ORAL203312-004Jan 7, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Apotex
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET, EXTENDED RELEASE;ORAL076212-001Jun 16, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET, ORALLY DISINTEGRATING;ORAL090631-002Jun 8, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
CARBIDOPA AND LEVODOPA
carbidopa; levodopa
TABLET, ORALLY DISINTEGRATING;ORAL090631-001Jun 8, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs Inc
RYTARY
carbidopa; levodopa
CAPSULE, EXTENDED RELEASE;ORAL203312-003Jan 7, 2015RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: carbidopa; levodopa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET CR
carbidopa; levodopa
TABLET, EXTENDED RELEASE;ORAL019856-002Dec 24, 1992► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET CR
carbidopa; levodopa
TABLET, EXTENDED RELEASE;ORAL019856-001May 30, 1991► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Merck Sharp Dohme
SINEMET
carbidopa; levodopa
TABLET;ORAL017555-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: carbidopa; levodopa

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2006073729► Subscribe
Japan2005528430► Subscribe
Hong Kong1215386► Subscribe
South Korea101569604► Subscribe
South Korea101451564► Subscribe
Taiwan200706182► Subscribe
South Korea20100099731► Subscribe
European Patent Office2234963► Subscribe
World Intellectual Property Organization (WIPO)2007016679► Subscribe
World Intellectual Property Organization (WIPO)2009085306► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Queensland Health
Novartis
Fuji
Healthtrust
Julphar
US Army
McKinsey
Cantor Fitzgerald
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot